Half cell solar panels, which divide conventional full-sized cells into two electrically independent halves, have moved from ...

No country has affected global solar panel supply chains more than the United States. Since the boom of solar in the early ...

Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...

Catalent made a series of deals early this decade to build up its presence in Gosselies. Now, it's planning to wind down cell ...

T1 Energy (TE) speculative buy: high-risk/high-reward US-made solar play. T1 is operating in a fast growing market that has a ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co‑led by investment funds managed by BlackRock and Eclipse, ...

Welcome to my first contribution to Solar Power World, part of a new series of articles looking specifically at U.S. solar ...

The proposed outlay is being examined as part of a possible incentive or PLI-linked framework aimed at reducing import ...